BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16649415)

  • 1. [Syndrome of persistent low levels of human chorionic gonadotrophin (hCG)].
    Zavadil M; Feyereisl J; Safár P; Pán M; Turyna R
    Ceska Gynekol; 2006 Mar; 71(2):136-42. PubMed ID: 16649415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis].
    Zavadil M; Feyereisl J; Safár P; Pán M
    Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistent trophoblastic disease in Trophoblastic Disease Center in the Czech Republic in 1955--2007].
    Zavadil M; Feyereisl J; Krofta L; Safár P; Turyna R
    Ceska Gynekol; 2008 Apr; 73(2):73-9. PubMed ID: 18567424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Undifferentiated choriocarcinoma--epithelioid trophoblastic tumors treated at the Center for Trophoblastic Diseases in the Czech Republic 1955-2003].
    Zavadil M; Feyereisl J; Safár P; Pán M
    Ceska Gynekol; 2003 Nov; 68(6):420-6. PubMed ID: 15042852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA; Kohorn E; Smith HO
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R; Ben-David Y
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY; Wong LC
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic gonadotropin assays and their uses.
    Tyrey L
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trophoblastic disease in data from the Center for Trophoblastic Disease (diagnosis, therapy and results form 1955 to 1996). 1].
    Zavadil M
    Ceska Gynekol; 1997 Apr; 62(2):67-71. PubMed ID: 9296795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease.
    Cole LA
    J Reprod Med; 1998 Jan; 43(1):3-10. PubMed ID: 9475142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin.
    Qian XQ; Chen LL; Li BH; Cheng XD; Wan XY
    J Obstet Gynaecol Res; 2016 Jun; 42(6):694-700. PubMed ID: 26916449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.